![](/images/graphics-bg.png)
Development of New Deep Venous Thrombosis While on Apixaban
Joint Authors
Khalighi, Koroush
Sharma, Munish
Ramanathan, Sabarina
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-06-20
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
The efficacy of novel oral anticoagulants (NOACs) in preventing deep venous thrombosis (DVT) has been established in large multicenter trials.
Predictable pharmacokinetics, avoidance of routine laboratory monitoring, and lesser drug interactions have made NOACs safer and more tolerable treatment option in comparison to warfarin.
However, cases of treatment failure mainly due to interindividual variation in plasma drug levels can be seen rarely.
In this report we describe a case of acute DVT of right lower extremity in a patient who was on apixaban for prevention of venous thromboembolism (VTE) due to underlying nonvalvular atrial fibrillation (NVAF).
American Psychological Association (APA)
Sharma, Munish& Ramanathan, Sabarina& Khalighi, Koroush. 2017. Development of New Deep Venous Thrombosis While on Apixaban. Case Reports in Cardiology،Vol. 2017, no. 2017, pp.1-3.
https://search.emarefa.net/detail/BIM-1143967
Modern Language Association (MLA)
Sharma, Munish…[et al.]. Development of New Deep Venous Thrombosis While on Apixaban. Case Reports in Cardiology No. 2017 (2017), pp.1-3.
https://search.emarefa.net/detail/BIM-1143967
American Medical Association (AMA)
Sharma, Munish& Ramanathan, Sabarina& Khalighi, Koroush. Development of New Deep Venous Thrombosis While on Apixaban. Case Reports in Cardiology. 2017. Vol. 2017, no. 2017, pp.1-3.
https://search.emarefa.net/detail/BIM-1143967
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1143967